PD-L1 Testing in Urothelial Carcinoma: Analysis of a Series of 1401 Cases Using Both the 22C3 and SP142 Assays

• मुख्य लेखकों: Harriet Evans (लेखक), Brendan O'Sullivan (लेखक), Frances Hughes (लेखक), Kathryn Charles (लेखक), Lee Robertson (लेखक), Philippe Taniere (लेखक), Salvador Diaz-Cano (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Immune checkpoint blockade (ICB) drugs are a novel, effective treatment for advanced urothelial carcinoma. Worldwide, several different ICB drugs are approved, each developed and clinically validated with a specific PD-L1 compound diagnostic assay. As a result, PD-L1 testing workflows in routine pra...